{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T19:07:06Z","timestamp":1791659226111,"version":"4.3.4"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81372437"],"award-info":[{"award-number":["81372437"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin J Cancer"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s40880-016-0152-9","type":"journal-article","created":{"date-parts":[[2016,10,12]],"date-time":"2016-10-12T19:46:32Z","timestamp":1476301592000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["ABO blood group is a predictor of survival in patients with laryngeal cancer"],"prefix":"10.1186","volume":"35","author":[{"given":"Ting","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Zhong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Han","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,13]]},"reference":[{"key":"152_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3322\/caac.21166","volume":"63","author":"R Siegel","year":"2013","unstructured":"Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63:11\u201330.","journal-title":"CA Cancer J Clin"},{"key":"152_CR2","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1093\/infdis\/jis698","volume":"207","author":"X Li","year":"2013","unstructured":"Li X, Gao L, Li H, Gao J, Yang Y, Zhou F, et al. Human papillomavirus infection and laryngeal cancer risk: a systematic review and meta-analysis. J Infect Dis. 2013;207:479\u201388.","journal-title":"J Infect Dis"},{"key":"152_CR3","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1017\/S0022215111002507","volume":"126","author":"SI Adam","year":"2012","unstructured":"Adam SI, Wilson KM, Overholser SM, Khabbaz E, Moreno K, Patil YJ. Are laryngeal squamous cell carcinoma incidence and patient mortality a function of ABO blood grouping? A retrospective study. J Laryngol Otol. 2012;126:180\u20134.","journal-title":"J Laryngol Otol"},{"key":"152_CR4","first-page":"266","volume":"24","author":"A Konieczna","year":"1992","unstructured":"Konieczna A, Turowski G. ABO blood groups system in laryngeal cancer patients and after survival of 3 and 5 years. Mater Med Pol. 1992;24:266\u20137.","journal-title":"Mater Med Pol"},{"issue":"20","key":"152_CR5","first-page":"396","volume":"49","author":"M Pyd","year":"1995","unstructured":"Pyd M, Rzewnicki I, Suwayach U. ABO blood groups in patients with laryngeal and hypopharyngeal cancer. Otolaryngology. 1995;49(20):396\u20138 (in Polish).","journal-title":"Otolaryngology"},{"issue":"31","key":"152_CR6","first-page":"209","volume":"54","author":"E Nowinska","year":"2000","unstructured":"Nowinska E, Namyslowski G, Scierski W, Kocierz S. ABO blood groups in the patients with laryngeal cancer. Otolaryngology. 2000;54(31):209\u201311 (in Polish).","journal-title":"Otolaryngology"},{"key":"152_CR7","first-page":"718","volume-title":"Principles of international medicine","author":"JS Dzieczkowski","year":"1998","unstructured":"Dzieczkowski JS, Anderson KC. Blood group antigens and therapy. In: Harrison TR, Fauci AS, editors. Principles of international medicine. 14th ed. New York: McGraw-Hill; 1998. p. 718\u20139.","edition":"14"},{"key":"152_CR8","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3109\/10408363.2012.708647","volume":"49","author":"M Franchini","year":"2012","unstructured":"Franchini M, Favaloro EJ, Targher G, Lippi G. ABO blood group, hypercoagulability, and cardiovascular and cancer risk. Crit Rev Clin Lab Sci. 2012;49:137\u201349.","journal-title":"Crit Rev Clin Lab Sci"},{"key":"152_CR9","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1053\/j.seminhematol.2004.01.001","volume":"41","author":"ME Reid","year":"2004","unstructured":"Reid ME, Mohandas N. Red blood cell blood group antigens: structure and function. Semin Hematol. 2004;41:93\u2013117.","journal-title":"Semin Hematol"},{"key":"152_CR10","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1002\/1097-0142(19800415)45:8<2149::AID-CNCR2820450823>3.0.CO;2-7","volume":"45","author":"JA Strauchen","year":"1980","unstructured":"Strauchen JA, Bergman SM, Hanson TA. Expression of A and B tissue isoantigens in benign and malignant lesions of the breast. Cancer. 1980;45:2149\u201355.","journal-title":"Cancer"},{"key":"152_CR11","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/ijc.2910470204","volume":"47","author":"MH Schuessler","year":"1991","unstructured":"Schuessler MH, Pintado S, Welt S, Real FX, Xu M, Melamed MR, et al. Blood group and blood-group-related antigens in normal pancreas and pancreas cancer: enhanced expression of precursor type 1, Tn and sialyl-Tn in pancreas cancer. Int J Cancer. 1991;47:180\u20137.","journal-title":"Int J Cancer"},{"key":"152_CR12","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1136\/bmj.1.4814.799","volume":"1","author":"I Aird","year":"1953","unstructured":"Aird I, Bentall HH, Roberts JA. A relationship between cancer of stomach and the ABO blood groups. Br Med J. 1953;1:799\u2013801.","journal-title":"Br Med J"},{"key":"152_CR13","doi-asserted-by":"publisher","first-page":"563","DOI":"10.3748\/wjg.v18.i6.563","volume":"18","author":"Y Gong","year":"2012","unstructured":"Gong Y, Yang YS, Zhang XM, Su M, Wang J, Han JD, et al. ABO blood type, diabetes and risk of gastrointestinal cancer in northern China. World J Gastroenterol. 2012;18:563\u20139.","journal-title":"World J Gastroenterol"},{"key":"152_CR14","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1002\/ijc.26220","volume":"130","author":"MA Gates","year":"2012","unstructured":"Gates MA, Xu M, Chen WY, Kraft P, Hankinson SE, Wolpin BM. ABO blood group and breast cancer incidence and survival. Int J Cancer. 2012;130:2129\u201337.","journal-title":"Int J Cancer"},{"key":"152_CR15","doi-asserted-by":"publisher","first-page":"e11972","DOI":"10.1371\/journal.pone.0011972","volume":"5","author":"J Xie","year":"2010","unstructured":"Xie J, Qureshi AA, Li Y, Han J. ABO blood group and incidence of skin cancer. PLoS One. 2010;5:e11972.","journal-title":"PLoS One"},{"key":"152_CR16","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1002\/ijc.26376","volume":"131","author":"DS Wang","year":"2012","unstructured":"Wang DS, Chen DL, Ren C, Wang ZQ, Qiu MZ, Luo HY, et al. ABO blood group, hepatitis B viral infection and risk of pancreatic cancer. Int J Cancer. 2012;131:461\u20138.","journal-title":"Int J Cancer"},{"key":"152_CR17","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1002\/ijc.28087","volume":"133","author":"L Sheng","year":"2013","unstructured":"Sheng L, Sun X, Zhang L, Su D. ABO blood group and nasopharyngeal carcinoma risk in a population of Southeast China. Int J Cancer. 2013;133:893\u20137.","journal-title":"Int J Cancer"},{"key":"152_CR18","first-page":"1","volume":"4","author":"F Tavasolian","year":"2014","unstructured":"Tavasolian F, Abdollahi E, Vakili M, Amini A. Relationship between ABO blood group and Acute Lymphoblastic Leukemia. Iran J Ped Hematol Oncol. 2014;4:1\u20134.","journal-title":"Iran J Ped Hematol Oncol"},{"key":"152_CR19","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1093\/jnci\/djp020","volume":"101","author":"BM Wolpin","year":"2009","unstructured":"Wolpin BM, Chan AT, Hartge P, Chanock SJ, Kraft P, Hunter DJ, et al. ABO blood group and the risk of pancreatic cancer. J Natl Cancer Inst. 2009;101:424\u201331.","journal-title":"J Natl Cancer Inst"},{"key":"152_CR20","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1038\/ng.429","volume":"41","author":"L Amundadottir","year":"2009","unstructured":"Amundadottir L, Kraft P, Stolzenberg-Solomon RZ, Fuchs CS, Petersen GM, Arslan AA, et al. Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet. 2009;41:986\u201390.","journal-title":"Nat Genet"},{"key":"152_CR21","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1158\/0008-5472.CAN-09-2993","volume":"70","author":"BM Wolpin","year":"2010","unstructured":"Wolpin BM, Kraft P, Gross M, Helzlsouer K, Bueno-de-Mesquita HB, Steplowski E, et al. Pancreatic cancer risk and ABO blood group alleles: results from the pancreatic cancer cohort consortium. Cancer Res. 2010;70:1015\u201323.","journal-title":"Cancer Res"},{"key":"152_CR22","doi-asserted-by":"publisher","first-page":"68","DOI":"10.5732\/cjc.013.10060","volume":"33","author":"HL Xu","year":"2014","unstructured":"Xu HL, Cheng JR, Zhang W, Wang J, Yu H, Ni QX, et al. Re-evaluation of ABO gene polymorphisms detected in a genome-wide association study and risk of pancreatic ductal adenocarcinoma in a Chinese population. Chin J Cancer. 2014;33:68\u201373.","journal-title":"Chin J Cancer."},{"key":"152_CR23","doi-asserted-by":"publisher","first-page":"e72311","DOI":"10.1371\/journal.pone.0072311","volume":"8","author":"AP Klein","year":"2013","unstructured":"Klein AP, Lindstrom S, Mendelsohn JB, Steplowski E, Arslan AA, Bueno-de-Mesquita HB, et al. An absolute risk model to identify individuals at elevated risk for pancreatic cancer in the general population. PLoS One. 2013;8:e72311.","journal-title":"PLoS One"},{"key":"152_CR24","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.1158\/1055-9965.EPI-10-0751","volume":"19","author":"BM Wolpin","year":"2010","unstructured":"Wolpin BM, Kraft P, Xu M, Steplowski E, Olsson ML, Arslan AA, et al. Variant ABO blood group alleles, secretor status, and risk of pancreatic cancer: results from the pancreatic cancer cohort consortium. Cancer Epidemiol Biomarkers Prev. 2010;19:3140\u20139.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"152_CR25","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.3892\/or.2013.2285","volume":"29","author":"C Rizzato","year":"2013","unstructured":"Rizzato C, Campa D, Pezzilli R, Soucek P, Greenhalf W, Capurso G, et al. ABO blood groups and pancreatic cancer risk and survival: results from the PANcreatic Disease ReseArch (PANDoRA) consortium. Oncol Rep. 2013;29:1637\u201344.","journal-title":"Oncol Rep"},{"key":"152_CR26","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1093\/jnci\/djq007","volume":"102","author":"HA Risch","year":"2010","unstructured":"Risch HA, Yu H, Lu L, Kidd MS. ABO blood group, Helicobacter pylori seropositivity, and risk of pancreatic cancer: a case-control study. J Natl Cancer Inst. 2010;102:502\u20135.","journal-title":"J Natl Cancer Inst"},{"key":"152_CR27","doi-asserted-by":"publisher","first-page":"6117","DOI":"10.1158\/1078-0432.CCR-14-0716","volume":"20","author":"BT Hofmann","year":"2014","unstructured":"Hofmann BT, Stehr A, Dohrmann T, Gungor C, Herich L, Hiller J, et al. ABO blood group IgM isoagglutinins interact with tumor-associated O-glycan structures in pancreatic cancer. Clin Cancer Res. 2014;20:6117\u201326.","journal-title":"Clin Cancer Res"},{"key":"152_CR28","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1038\/bjc.2013.559","volume":"109","author":"PY Ouyang","year":"2013","unstructured":"Ouyang PY, Su Z, Mao YP, Liu Q, Xie FY. Prognostic value of ABO blood group in southern Chinese patients with established nasopharyngeal carcinoma. Br J Cancer. 2013;109:2462\u20136.","journal-title":"Br J Cancer"},{"key":"152_CR29","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1158\/1055-9965.EPI-06-0353","volume":"15","author":"ET Chang","year":"2006","unstructured":"Chang ET, Adami HO. The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev. 2006;15:1765\u201377.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"152_CR30","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1016\/S0140-6736(05)66698-6","volume":"365","author":"WI Wei","year":"2005","unstructured":"Wei WI, Sham JS. Nasopharyngeal carcinoma. Lancet. 2005;365:2041\u201354.","journal-title":"Lancet"},{"key":"152_CR31","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/j.juro.2013.11.106","volume":"191","author":"T Klatte","year":"2014","unstructured":"Klatte T, Xylinas E, Rieken M, Kluth LA, Roupret M, Pycha A, et al. Impact of ABO blood type on outcomes in patients with primary nonmuscle invasive bladder cancer. J Urol. 2014;191:1238\u201343.","journal-title":"J Urol"},{"key":"152_CR32","doi-asserted-by":"publisher","first-page":"7201","DOI":"10.1007\/s13277-014-1960-7","volume":"35","author":"P Sun","year":"2014","unstructured":"Sun P, Chen C, Zhang F, An X, Li XY, Li YH, et al. The ABO blood group predicts survival in esophageal squamous cell carcinoma in patients who ever smoked: a retrospective study from China. Tumour Biol. 2014;35:7201\u20138.","journal-title":"Tumour Biol"},{"key":"152_CR33","doi-asserted-by":"publisher","first-page":"131","DOI":"10.7314\/APJCP.2012.13.1.131","volume":"13","author":"H Engin","year":"2012","unstructured":"Engin H, Bilir C, Ustun H, Gokmen A. ABO blood group and risk of pancreatic cancer in a Turkish population in Western Blacksea region. Asian Pac J Cancer Prev. 2012;13:131\u20133.","journal-title":"Asian Pac J Cancer Prev"},{"key":"152_CR34","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1186\/1471-2407-12-319","volume":"12","author":"NN Rahbari","year":"2012","unstructured":"Rahbari NN, Bork U, Hinz U, Leo A, Kirchberg J, Koch M, et al. ABO blood group and prognosis in patients with pancreatic cancer. BMC Cancer. 2012;12:319.","journal-title":"BMC Cancer"},{"key":"152_CR35","doi-asserted-by":"publisher","first-page":"E641","DOI":"10.1111\/j.1464-410X.2012.11366.x","volume":"110","author":"SD Kaffenberger","year":"2012","unstructured":"Kaffenberger SD, Morgan TM, Stratton KL, Boachie AM, Barocas DA, Chang SS, et al. ABO blood group is a predictor of survival in patients undergoing surgery for renal cell carcinoma. BJU Int. 2012;110:E641\u20136.","journal-title":"BJU Int"},{"key":"152_CR36","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s40880-015-0054-2","volume":"34","author":"N Li","year":"2015","unstructured":"Li N, Xu M, Li CF, Ou W, Wang BX, Zhang SL, et al. Prognostic role of the ABO blood types in Chinese patients with curatively resected non-small cell lung cancer: a retrospective analysis of 1601 cases at a single cancer center. Chin J Cancer. 2015;34:54.","journal-title":"Chin J Cancer"}],"container-title":["Chinese Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40880-016-0152-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,5,12]],"date-time":"2018-05-12T16:57:42Z","timestamp":1526144262000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancercommun.biomedcentral.com\/articles\/10.1186\/s40880-016-0152-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,13]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["152"],"URL":"https:\/\/doi.org\/10.1186\/s40880-016-0152-9","relation":{},"ISSN":["1944-446X"],"issn-type":[{"value":"1944-446X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,13]]},"article-number":"90"}}